Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Prescription transactions revenue146.75M73.15%
Pharma manufacturer solutions revenue26.5M13.21%
Subscription Revenue21.95M10.94%
Other revenue5.41M2.69%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States750.27M100.00%